How Testosterone Became a Cultural Obsession
Testosterone has moved from endocrinology textbooks into everyday conversation. Prescriptions have soared, from under one million in 2000 to nearly 12 million in 2025, and that figure likely misses the growing number of men sourcing hormones through telehealth platforms and informal channels. High-profile advocates, from podcast hosts to senior health officials, openly discuss testosterone replacement therapy (TRT), framing it as a path to renewed energy, confidence and youth. Online, a hypermasculine aesthetic amplifies the trend: muscular tech leaders, “T-maxxing” fitness influencers and lifestyle gurus presenting testosterone as a shortcut to peak performance. This cultural wave casts testosterone as both a symbol and solution for perceived male decline, while health authorities consider expanding access to TRT. Yet doctors warn that a therapy with real risks is being recast as a lifestyle enhancer, blurring the line between legitimate treatment and hormone-driven self-optimization.
From Hypogonadism to ‘Low T’: A Pseudo-Disease?
Clinically, testosterone deficiency is known as hypogonadism: a condition in which the testes or hormonal signaling pathways cannot produce enough testosterone. Diagnosis requires both consistently low hormone levels and characteristic symptoms such as loss of morning erections, low libido, infertility, weight gain, osteoporosis or depression. Critics argue that this precise definition is being diluted as “low T” becomes a catch-all label for common midlife complaints. Endocrinologists report that rising numbers of men, especially younger ones, are crowding clinics after online ads and social media posts convince them they are hormonally broken. Some specialists describe low testosterone marketing as inventing a “spurious pseudo-disease,” turning normal variation in hormone levels or lifestyle-related fatigue into a medical diagnosis. While genuine hypogonadism can be life-altering when treated, the expanding category of “low T diagnosis” risks pathologising ordinary experience and feeding anxiety among otherwise healthy men.
Men’s Health Companies and the Business of Low Testosterone
Direct-to-consumer men’s health companies have transformed testosterone into a branded product. Platforms offering blood tests, virtual consultations and doorstep delivery target men worried about erectile dysfunction, hair loss, weight gain and low drive. Because advertising prescription testosterone directly is restricted in many jurisdictions, these companies promote tests and symptom quizzes instead, nudging users toward treatment. One man whose testosterone levels fell within the normal range on a public health service test turned to a private online provider after feeling dismissed; a few blood draws and a video call later, he was on lifelong TRT. Market research shows testosterone prescriptions surging, and clinicians say demand is fed by aggressive low testosterone marketing that frames vague irritability or low motivation as hormonal failure. This business model blurs health care and consumerism, encouraging men to view testosterone as a customizable upgrade rather than a tightly regulated therapy for a specific disorder.
Influencers, T‑Maxxing and the New Masculinity Script
Social media influencers have become powerful amplifiers of testosterone treatment myths. On platforms like TikTok, “T-maxxing” content promises to optimise masculinity through sleep, diet, heavy lifting and, increasingly, pharmaceutical hormones or steroids. Some men who report dramatic improvements on TRT become influencers themselves, using their personal transformations to recruit followers and promote specific clinics or brands. Within online subcultures, “low T” is hurled as an insult alongside “beta” and “simp,” implying that hormonal status defines a man’s worth. Public figures touting testosterone as part of anti-ageing regimens add to the perception that normal ageing equals deficiency. Posters on public transit suggest that feeling irritable might mean low testosterone, subtly teaching men to interpret emotional states as chemical problems. This cultural script narrows the idea of manhood to lab numbers and muscle mass, and subtly sidelines social, psychological and lifestyle factors that also shape male wellbeing.
A Real Treatment with Real Risks—and Real Limits
Behind the hype, clinicians highlight a basic point: testosterone therapy is essential for some men and unnecessary, even harmful, for others. For men with documented hypogonadism, TRT can restore energy, libido, fertility prospects and bone health, sometimes transforming daily life. But once on therapy, the body often reduces or stops its own testosterone production, making treatment effectively lifelong. Doctors worry about men starting TRT based on a single borderline reading, a marketing-driven low T diagnosis or expectations shaped by influencers rather than careful evaluation. Potential risks include thickened blood, cardiovascular strain and fertility problems, especially when doses or monitoring are inadequate. Experts advocate strict diagnostic criteria, repeat morning blood tests and attention to symptoms before prescribing. They also urge addressing sleep, diet, exercise, mental health and alcohol use. The real challenge is narrowing the gap between medical necessity and marketing, so testosterone remains a tool of medicine, not a symbol of masculinity.